effects of a short therpay of zolpidem with support servo-ventilation versus placebo in patients with central sleep apnea with chronic heart failure

effects of a short therpay of zolpidem with support servo-ventilation versus placebo in patients with central sleep apnea with chronic heart failure - ZODIAC

Status

Not yet recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2015-003119-39-FR

Enrollment

Unknown

Registered

2016-02-25

Start date

2015-10-29

Completion date

Unknown

Last updated

2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic heart failure and central sleep apnea MedDRA version: 18.1 Level: PT Classification code 10040979 Term: Sleep apnoea syndrome System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders MedDRA version: 18.1 Level: LLT Classification code 10019276 Term: Heart disease, unspecified System Organ Class: 100000004849

Interventions

Trade Name: stilnox Product Name: zolpidem Pharmaceutical Form: Buccal tablet Pharmaceutical form of the placebo: Buccal tablet Route of administration of the placebo: Oral use

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: please report to the french version Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 30 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 18

Exclusion criteria

Exclusion criteria: please report to the french version

Design outcomes

Primary

Measure	Time frame
Main Objective: please report to the french version;Secondary Objective: please report to the french version;Primary end point(s): please report to the french version;Timepoint(s) of evaluation of this end point: please report to the french version	—

Secondary

Measure	Time frame
Secondary end point(s): please report to the french version;Timepoint(s) of evaluation of this end point: please report to the french version	—

Countries

France

Contacts

Public ContactARC promoteur

Direction de la recherche Clinique

MCoutard@chu-grenoble.fr+330476 76 84 55

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026